Pharmaris- K Extencaps
Natural health product licensed in Canada
- Other names
- Pharmaris- K 8 mEq Extencaps, Pharmaris- K Extencaps 600mg Capsules
- Licence holder
- Pharmaris Canada Inc.
- NPN or DIN-HM
- 80111121
- Status
- Active licence
- Licence date
- 2 July 2021
- Revision date
- Not provided
- Form
- Capsule, libération retardée
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Décanedioate de dibutyle, Éthylcellulose, Laque d'aluminium jaune FD&C No. 6, Stéarate de magnésium, Laque d'aluminium bleu FD&C No 2, Acide citrique monohydraté, Lauryl sulfate de sodium, Hydroxypropylméthylcellulose, Rouge FD&C N° 40, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | 1 Tous les jours |
| Adultes | Not specified | minimum: 5 Capsule ; maximum: 12 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
For the treatment or prevention of hypokalemia (potassium depletion) which does not result from dietary deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80111121
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.